X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

ACTA OPHTHALMOLOGICA

期刊標題檢索 ACTA OPHTHALMOL 最新評論: Submission success rate: 25.0 Experience sharing: Submitted a meta a... (2024-01-24)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[ACTA OPHTHALMOLOGICA]您好,您是該頁面的第 37070 位訪客。

期刊簡介
期刊名稱ACTA OPHTHALMOLOGICA ACTA OPHTHALMOLOGICA
LetPub Score
6.4
50 ratings
Rate

Reputation
7.5

Influence
5.2

Speed
8.2

期刊簡稱ACTA OPHTHALMOL
ISSN1755-375X
E-ISSN1755-3768
h-index77
CiteScore
CiteScoreSJRSNIPCiteScore Rank
7.601.4041.496
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Ophthalmology
Q115 / 137

自引率 (2023-2024)6.70%自引率趨勢
掲載範囲
Acta Ophthalmologica is published on behalf of the Acta Ophthalmologica Scandinavica Foundation and is the official scientific publication of the following societies: The Danish Ophthalmological Society, The Finnish Ophthalmological Society, The Icelandic Ophthalmological Society, The Norwegian Ophthalmological Society and The Swedish Ophthalmological Society, and also the European Association for Vision and Eye Research (EVER).

Acta Ophthalmologica publishes clinical and experimental original articles, reviews, editorials, educational photo essays (Diagnosis and Therapy in Ophthalmology), case reports and case series, letters to the editor and doctoral theses.
官方網站http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1755-3768
在線稿件提交https://mc.manuscriptcentral.com/acta
開放訪問No
出版商Wiley-Blackwell Publishing Ltd
主題領域医学
出版國/地區DENMARK
發行頻率隔月刊行
創刊年0
每年文章數171每年文章數趨勢
黃金OA百分比42.33%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
OPHTHALMOLOGYSCIEQ118/95
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1755-375X%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 6 Month(s)
競爭力 *來自作者的數據: About 75%
參考鏈接
相關期刊 【ACTA OPHTHALMOLOGICA】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    PROGRESS IN RETINAL AND EYE RESEARCHH-index: 131

    CiteScore: 34.10
    OPHTHALMOLOGYH-index: 217

    CiteScore: 22.30
    Ocular SurfaceH-index: 53

    CiteScore: 11.60
    SURVEY OF OPHTHALMOLOGYH-index: 120

    CiteScore: 10.30
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCEH-index: 196

    CiteScore: 6.90
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGYH-index: 67

    CiteScore: 7.60
    AMERICAN JOURNAL OF OPHTHALMOLOGYH-index: 171

    CiteScore: 9.20
    BRITISH JOURNAL OF OPHTHALMOLOGYH-index: 137

    CiteScore: 10.30
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIEH-index: 44

    CiteScore: 3.20
    CURRENT OPINION IN OPHTHALMOLOGYH-index: 79

    CiteScore: 6.80
    學科內最受檢索的期刊 頁面查看次數
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE67688
    OPHTHALMOLOGY43596
    EXPERIMENTAL EYE RESEARCH43411
    BRITISH JOURNAL OF OPHTHALMOLOGY41008
    EYE40962
    CURRENT EYE RESEARCH38542
    CORNEA37639
    AMERICAN JOURNAL OF OPHTHALMOLOGY35742
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY33293
    JOURNAL OF VISION30422
  •  

    ACTA OPHTHALMOLOGICA ACTA OPHTHALMOLOGICA
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [ACTA OPHTHALMOLOGICA] 的評論撰寫評論
作者: 墟散冷松


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-24 15:12:11 評論於
Submission success rate: 25.0 Experience sharing: Submitted a meta article, and it was rejected the next day. Maybe I didn't write it well. The journal has pretty high standards
(0) 讚! | 墟散冷松

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 18:38:37 評論於
It is generally believed that titles and keywords complement each other around the research topic
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 10:55:52 評論於
Keywords should be avoided in the title. Most journals have this recommendation
(0) 讚! | 维尔娜菲茨杰拉德

作者: 八坂篷蔚


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 23:08:13 評論於
Can keywords be extracted from the title?
(0) 讚! | 八坂篷蔚

作者: 八坂篷蔚


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 20:28:41 評論於
The relationship between keywords and titles lies in the ability of keywords to accurately reflect the content and main ideas of the title. By incorporating relevant keywords into the title, it can help improve the visibility and searchability of the content
(0) 讚! | 八坂篷蔚

作者: Christine Shelley


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-08-08 13:02:27 評論於
Review speed: 6.0 | Submission acceptance rate: 25.0
Experience sharing: Submitted for 10 days and still waiting to be reviewed, very slow, not recommended for submission
(0) 讚! | Christine Shelley

作者: 北国天路


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-07-26 20:51:18 評論於
Review Speed: 3.0 | Submission Acceptance Rate: 25.0
Experience Sharing: It's been a week since submission, but still awaiting AE assignment, a bit slow
(0) 讚! | 北国天路

作者: 大力含蓉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-05-04 16:07:53 評論於
Received a meta-analysis?
(0) 讚! | 大力含蓉

作者: 白骨家欣


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-05-16 15:49:59 評論於
Review speed: 6.0 | Submission acceptance rate: 25.0
Experience sharing: This journal is very quick to reject some articles. The editors will do an initial evaluation. If the articles do not meet the requirements, they are usually rejected within about two weeks. However, if they pass the initial review, the process will take at least one and a half months and may even take up to half a year
(0) 讚! | 白骨家欣

作者: 明冠凝然


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-09-13 22:33:23 評論於
How long does the second review take? This magazine is very rigorous. The score is relatively stable. It is suitable for Chinese people to contribute. But if you want to graduate or submit a paper when you leave, you must be cautious. The review period is not as long as 6 months, but it is not fast either. Recently, I submitted a paper. It took 1 month and 45 days for the first review and revision. There were not many comments. After 25 days of revision, it has been 1 month now. It is still waiting for assignment review. It's really urgent. Waiting for it to be sent out! It will definitely not be sent out on time. It's so tragic. Remember, be cautious when submitting papers!
(0) 讚! | 明冠凝然

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-18 19:02:41 評論於
3 points up, hoping to maintain stability, a slight increase is also good
(0) 讚! | 凌霄高洁

作者: 恨瑶酱大魔王


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-02-07 10:04:37 評論於
Review Speed: 3.0 | Submission Acceptance Rate: 25.0
Sharing experience: Submitted on October 27, 2016, rejected on February 5, 2017. Only the opinion of the editor-in-chief
(0) 讚! | 恨瑶酱大魔王

作者: 碧桃梓希


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-07-07 23:08:06 評論於
Magazines are very rigorous, with relatively stable scores, suitable for Chinese submissions, but if you want to graduate or submit to a station, you must be careful. The review period is not as long as 6 months, but not fast either. Recently I submitted an article, and it took 45 days for the first review and revision, with minor suggestions. After 25 days of revision, it has been a month now, still waiting for assignment reviewer. I am so anxious, waiting for it to be accepted! It definitely won't be accepted on time, how miserable. Remember, submitting articles must be careful!
(0) 讚! | 碧桃梓希

作者: Anonymous


領域: 医药科学
審稿時間: 6.0 month(s)
結果: 待定&不明


撰寫評論

2016-07-07 14:09:08 評論於
This journal is a very rigorous with a strong score, and suitable for international researchers to contribute to. However, the review cycle is long (up to six months), so be cautious about submitting anything that you need published quickly.

(0) 讚! | Anonymous

作者: Glenn Truman


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-03-02 23:18:15 評論於
This journal is very rigorous and the review process is relatively stable, suitable for Chinese submissions. However, if you want to submit for graduation or for publication outside the country, you must be cautious. The review period is not as long as six months, but it is not fast either. Recently, I submitted an article, which was reviewed and revised in 45 days. There weren't many comments. After 25 days of revision, it has been a month now and I am still waiting for the assignment reviewer. I am anxious to see it published! It definitely won't be published on time, it's so tragic. Remember, submitting articles must be done carefully!
(0) 讚! | Glenn Truman

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-05-22 11:15:21 評論於
Received last November, but still not on PubMed online, urgent
(0) 讚! | 凌霄高洁

作者: 孤云平彤


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-04-21 21:42:35 評論於
Please translate the following paragraph into English and Japanese, and title with ":" and ":"
(0) 讚! | 孤云平彤

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2012-11-28 12:39:33 評論於
Can we hit 3 points next year? Let's discuss
(0) 讚! | 凌霄高洁

作者: 暴风溥心


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-10-19 19:41:45 評論於
Review speed: 6.0 | Submission success rate: 75.0
Experience sharing: Submitting SCI papers after graduation
(0) 讚! | 暴风溥心

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [ACTA OPHTHALMOLOGICA] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*